NASDAQ:SMMT - SUMMIT THERAPEU/S News Headlines

$1.24
-0.02 (-1.59 %)
(As of 06/17/2019 03:25 AM ET)
Today's Range
$1.23
Now: $1.24
$1.3035
50-Day Range
$1.27
MA: $1.65
$1.91
52-Week Range
$1.10
Now: $1.24
$13.39
Volume23,387 shs
Average Volume36,958 shs
Market Capitalization$17.16 million
P/E Ratio1.48
Dividend YieldN/A
Beta1.45

Headlines

SUMMIT THERAPEU/S (NASDAQ SMMT) News Headlines

Source:
DateHeadline
SUMMIT THERAPEU/S (NASDAQ:SMMT) Receives Consensus Recommendation of "Hold" from AnalystsSUMMIT THERAPEU/S (NASDAQ:SMMT) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 13 at 2:17 AM
Zacks: Brokerages Anticipate SUMMIT THERAPEU/S (NASDAQ:SMMT) Will Post Quarterly Sales of $4.34 MillionZacks: Brokerages Anticipate SUMMIT THERAPEU/S (NASDAQ:SMMT) Will Post Quarterly Sales of $4.34 Million
www.americanbankingnews.com - June 11 at 4:48 AM
 Analysts Anticipate SUMMIT THERAPEU/S (NASDAQ:SMMT) to Announce -$0.31 Earnings Per Share Analysts Anticipate SUMMIT THERAPEU/S (NASDAQ:SMMT) to Announce -$0.31 Earnings Per Share
www.americanbankingnews.com - June 9 at 2:06 AM
Bridgend closure highlights fragile state of car industryBridgend closure highlights fragile state of car industry
www.ft.com - June 8 at 9:21 AM
UK Annual Report and Notice of AGMUK Annual Report and Notice of AGM
finance.yahoo.com - May 14 at 6:43 PM
Sarepta: Buy The Pfizer SelloffSarepta: Buy The Pfizer Selloff
seekingalpha.com - May 1 at 5:56 PM
Exercise of Restricted Stock UnitsExercise of Restricted Stock Units
finance.yahoo.com - April 24 at 5:20 PM
Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
finance.yahoo.com - April 12 at 10:28 AM
Summit Therapeutics Swings To Annual Profit On Sarepta AgreementSummit Therapeutics Swings To Annual Profit On Sarepta Agreement
www.morningstar.co.uk - March 27 at 6:05 PM
Summit Therapeutics Has Started Attracting Institutional Investors AgainSummit Therapeutics Has Started Attracting Institutional Investors Again
seekingalpha.com - March 25 at 6:00 PM
INmune Bio Co-Founder and CEO Presented at Cambridge Healthtech Institutes 4th Annual Immuno-Oncology Summit Europe 2019 - GlobeNewswireINmune Bio Co-Founder and CEO Presented at Cambridge Healthtech Institute's 4th Annual Immuno-Oncology Summit Europe 2019 - GlobeNewswire
globenewswire.com - March 19 at 6:03 PM
Summit Therapeutics adds to SMT-571-stoked rally, up 18%Summit Therapeutics adds to SMT-571-stoked rally, up 18%
seekingalpha.com - February 27 at 5:41 PM
Summits SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data - GlobeNewswireSummit's SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data - GlobeNewswire
globenewswire.com - February 25 at 8:43 AM
Summit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical DataSummit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data
finance.yahoo.com - February 25 at 8:43 AM
Sarepta Therapeutics - Is A Brief Stint At $190 A Share In The Cards For The Near Future?Sarepta Therapeutics - Is A Brief Stint At $190 A Share In The Cards For The Near Future?
seekingalpha.com - February 19 at 5:39 PM
Leading Austin-Based Entrepreneurs to Speak at Groundbreaking Innovation Summit - PRNewswireLeading Austin-Based Entrepreneurs to Speak at Groundbreaking Innovation Summit - PRNewswire
www.prnewswire.com - February 6 at 10:05 AM
Award of Restricted Stock UnitsAward of Restricted Stock Units
finance.yahoo.com - January 14 at 9:13 AM
Europes Top Healthcare Start-ups in Biotech, Medtech and Digital Health Win Cash and Recogniton at EIT Health Summit - PRNewswireEurope's Top Healthcare Start-ups in Biotech, Medtech and Digital Health Win Cash and Recogniton at EIT Health Summit - PRNewswire
www.prnewswire.com - December 6 at 4:28 PM
Scrapping UK grants for hybrid cars astounding, says industryScrapping UK grants for hybrid cars 'astounding', says industry
www.msn.com - October 12 at 4:09 PM
UK car industry launches contingency program for no deal BrexitUK car industry launches contingency program for 'no deal' Brexit
www.msn.com - October 10 at 9:24 AM
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018
www.bizjournals.com - October 3 at 4:09 PM
Can Summit Therapeutics plc (LON:SUMM) Continue To Outperform Its Industry?Can Summit Therapeutics plc (LON:SUMM) Continue To Outperform Its Industry?
finance.yahoo.com - September 25 at 4:15 PM
Summit Therapeutics Swings To Profit On Sarepta Licence RevenueSummit Therapeutics Swings To Profit On Sarepta Licence Revenue
www.morningstar.co.uk - September 20 at 4:10 PM
Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment ConferenceSummit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
finance.yahoo.com - August 29 at 9:57 AM
Why Summit Therapeutics Is One of Thursday’s Top BiotechsWhy Summit Therapeutics Is One of Thursday’s Top Biotechs
www.msn.com - August 16 at 4:12 PM
Summits ridinilazole beats vancomycin in C. diff studySummit's ridinilazole beats vancomycin in C. diff study
seekingalpha.com - August 2 at 4:12 PM
Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile InfectionPhase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile Infection
finance.yahoo.com - August 2 at 4:12 PM
Summit Therapeutics Joins Antimicrobials Working GroupSummit Therapeutics Joins Antimicrobials Working Group
finance.yahoo.com - July 30 at 4:11 PM
KemPharm Stock Down Despite Positive Data on ADHD CandidateKemPharm Stock Down Despite Positive Data on ADHD Candidate
finance.yahoo.com - July 10 at 4:17 PM
UK car prices could rise by £1,500 after BrexitUK car prices could rise by £1,500 after Brexit
uk.finance.yahoo.com - July 5 at 9:10 AM
Summit Tumbles 80% On Phase 2 DMD Failure, But The Stock Is Still Worth A LookSummit Tumbles 80% On Phase 2 DMD Failure, But The Stock Is Still Worth A Look
seekingalpha.com - June 30 at 11:52 AM
Massive Biopharma Movers of the Past WeekMassive Biopharma Movers of the Past Week
www.msn.com - June 30 at 11:52 AM
Mid-Day Market Update: Crude Oil Up Over 3%; Aquinox Pharmaceuticals Shares PlungeMid-Day Market Update: Crude Oil Up Over 3%; Aquinox Pharmaceuticals Shares Plunge
www.benzinga.com - June 27 at 4:28 PM
Summit Therapeutics -80% after discontinuing top drug candidateSummit Therapeutics -80% after discontinuing top drug candidate
seekingalpha.com - June 27 at 4:28 PM
Mid-Morning Market Update: Markets Open Higher; Conagra To Acquire Pinnacle FoodsMid-Morning Market Update: Markets Open Higher; Conagra To Acquire Pinnacle Foods
www.benzinga.com - June 27 at 11:50 AM
‘Hard Brexit’ Will Put 860,000 Jobs At Risk, UK Car Manufacturers Warn Theresa May‘Hard Brexit’ Will Put 860,000 Jobs At Risk, UK Car Manufacturers Warn Theresa May
www.msn.com - June 26 at 11:27 AM
Theresa May promises to listen to business over BrexitTheresa May promises to listen to business over Brexit
www.ft.com - June 26 at 11:27 AM
Brexits ‘Death by a Thousand Cuts’ Has U.K. Automakers on EdgeBrexit's ‘Death by a Thousand Cuts’ Has U.K. Automakers on Edge
www.msn.com - June 26 at 11:27 AM
Foreign businesses to UK: solve Brexit or risk £100bn in tradeForeign businesses to UK: solve Brexit or risk £100bn in trade
www.msn.com - June 25 at 11:23 AM
Sarepta Therapeutics - Enjoy Sub $100 A Share Valuation While It LastsSarepta Therapeutics - Enjoy Sub $100 A Share Valuation While It Lasts
seekingalpha.com - June 11 at 4:20 PM
Sales of new diesel cars fall by almost a quarter in MaySales of new diesel cars fall by almost a quarter in May
www.ft.com - June 5 at 9:19 AM
‘Green shoots’: UK car production accelerates 5% in April‘Green shoots’: UK car production accelerates 5% in April
www.ft.com - May 31 at 9:59 AM
Sarepta Therapeutics: The Art Of Rallying Off Of Bad NewsSarepta Therapeutics: The Art Of Rallying Off Of Bad News
seekingalpha.com - May 7 at 4:23 PM
3 Things In Biotech, April 23: Support, Support, And Those Blasted Blood Vessels3 Things In Biotech, April 23: Support, Support, And Those Blasted Blood Vessels
seekingalpha.com - April 24 at 9:40 AM
Summit Therapeutics (SMMT) Presents At H. C. Wainwright Global Life Sciences Conference - SlideshowSummit Therapeutics (SMMT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
seekingalpha.com - April 11 at 4:16 PM
Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences ConferenceSummit Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
globenewswire.com - April 5 at 8:45 AM
Summit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual MeetingSummit Therapeutics Selected for Emerging Science Presentation at the 2018 American Academy of Neurology Annual Meeting
finance.yahoo.com - April 5 at 8:45 AM
Summits Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against ... - GlobeNewswire (press release)Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 10:48 AM
Summit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against GonorrhoeaSummit’s Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea
finance.yahoo.com - March 13 at 10:07 AM
Summit Therapeutic (SMMT) Says Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data from PhaseOut DMD Clinical TrialSummit Therapeutic (SMMT) Says Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data from PhaseOut DMD Clinical Trial
www.streetinsider.com - January 27 at 9:16 AM
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel